Literature DB >> 24630741

Psychosis-proneness correlates with expression levels of dopaminergic genes.

P Grant1, F Gabriel2, Y Kuepper2, C Wielpuetz2, J Hennig2.   

Abstract

Psychosis-proneness or schizotypy is a personality organisation mirroring individual risk for schizophrenia-development. Believed to be a fully dimensional construct sharing considerable geno- and phenotypal variance with clinical schizophrenia, it has become an increasingly promising tool for basic psychosis-research. Although many studies show genetic commonalities between schizotypy and schizophrenia, changes in regulation of gene expression have never been examined in schizotypy before. We therefore extracted RNA from the blood, a valid surrogate for brain tissue, of a large sample of 67 healthy male volunteers and correlated the activities of all genes relevant for dopaminergic neurotransmission with the positive schizotypy-scale of the O-LIFE. We found significant negative correlations regarding the expression of the genes COMT, MAOB, DRD4, DRD5 and FOS, indicating that increased schizotypy coincides with higher levels of dopaminergic dysregulation on the mRNA-level. Considering the advantages of this method, we suggest that it be applied more often in fundamental psychosis-research.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Endophenotype; Gene expression; Molecular biology; Psychosis proneness; Schizophrenia and psychosis; Schizotypy

Mesh:

Substances:

Year:  2014        PMID: 24630741     DOI: 10.1016/j.eurpsy.2013.12.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  8 in total

1.  Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling.

Authors:  Russell W Brown; Christopher G Varnum; Liza J Wills; Loren D Peeters; Justin T Gass
Journal:  Pharmacol Biochem Behav       Date:  2021-10-25       Impact factor: 3.697

2.  Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia.

Authors:  Mariana Maschietto; Ana C Tahira; Renato Puga; Leandro Lima; Daniel Mariani; Bruna da Silveira Paulsen; Paulo Belmonte-de-Abreu; Henrique Vieira; Ana Cv Krepischi; Dirce M Carraro; Joana A Palha; Stevens Rehen; Helena Brentani
Journal:  BMC Med Genomics       Date:  2015-05-16       Impact factor: 3.063

Review 3.  The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders.

Authors:  Neus Barrantes-Vidal; Phillip Grant; Thomas R Kwapil
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 4.  Genetic Consideration of Schizotypal Traits: A Review.

Authors:  Emma E Walter; Francesca Fernandez; Mollie Snelling; Emma Barkus
Journal:  Front Psychol       Date:  2016-11-15

5.  Potential diagnostic markers of olanzapine efficiency for acute psychosis: a focus on peripheral biogenic amines.

Authors:  A E Taraskina; R F Nasyrova; A M Zabotina; D N Sosin; К А Sosina; E E Ershov; M N Grunina; E M Krupitsky
Journal:  BMC Psychiatry       Date:  2017-12-08       Impact factor: 3.630

6.  Distress severity in perceptual anomalies moderates the relationship between prefrontal brain structure and psychosis proneness in nonclinical individuals.

Authors:  Ulrika Evermann; Simon Schmitt; Tina Meller; Julia-Katharina Pfarr; Sarah Grezellschak; Igor Nenadić
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-02-02       Impact factor: 5.270

7.  Transgenerational evidence of increases in dopamine D2 receptor sensitivity in rodents: Impact on sensorimotor gating, the behavioral response to nicotine and BDNF.

Authors:  Wesley Drew Gill; Katherine C Burgess; Cynthia Vied; Russell W Brown
Journal:  J Psychopharmacol       Date:  2021-07-22       Impact factor: 4.562

8.  Nonclinical psychotic-like experiences and schizotypy dimensions: Associations with hippocampal subfield and amygdala volumes.

Authors:  Ulrika Evermann; Christian Gaser; Tina Meller; Julia-Katharina Pfarr; Sarah Grezellschak; Igor Nenadić
Journal:  Hum Brain Mapp       Date:  2021-07-24       Impact factor: 5.038

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.